EMR Data (Commercial)
Our RWE solutions combine the richest patient-centered evidence base with innovative technologies to deliver unparalleled insights into disease, treatment and outcomes. Electronic Medical Records (EMR) data, within the context of a commercial effectiveness study, is available for:
- Market opportunity assessments
- Launch tracking, KPIs
- RWE-enabled marketing (e.g. undertreated)
The information is the record from the patient visit, linked to administrative information and lab results. It is longitudinal and has history back to 2008 for retrospective studies. For prospective studies additional insights such as patient surveys, QOL insights and physician commentary on prescribing decisions adds further unique value.
These assets can be leveraged in custom studies performed by our Commercial Effectiveness Services’ consultants. Additionally, access can be provided to the underlying data via custom therapy-area data marts with anonymous patient data records linked across the sources.